Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 26Urinary Bladder Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 13Ovarian Neoplasms 10Nasopharyngeal Carcinoma 9Biliary Tract Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 7Neoplasm Metastasis 7Cholangiocarcinoma 7Lymphoma, Large B-Cell, Diffuse 6Triple Negative Breast Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Osteosarcoma 3Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Urologic Neoplasms 2Rectal Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Gallbladder Neoplasms 2Colonic Neoplasms 2

Interventions

pembrolizumab 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Cisplatin 1Cetuximab 1Carboplatin 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Pancreatic Ductal × Gemcitabine × 30 days × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡